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ABSTRACT
Axonal Regrowth of Olfactory Sensory Neurons After Chemical Ablation and Removal
of Axonal Debris by Microglia
by
Rudy Chapman

Olfactory sensory neurons (OSNs) are contained within the olfactory epithelium (OE)
and are responsible for detecting odorant molecules in the air. The exposure of OSNs to
the external environment is necessary for their function, but it also leaves them exposed
to potentially harmful elements and thus results in a high turnover rate. Despite the high
turnover, the olfactory sense is maintained throughout life through the division of a
population of stem cells that produce new OSNs both during normal turnover and after
an injury occurs in the OE. When new OSNs are born, they must extend axons from the
OE to the olfactory bulb (OB) where they make specific synaptic contacts. To determine
the timeline of axon extension in normal turnover and after a methimazole-induced
injury, we used fate-tracing utilizing an inducible Cre-LoxP model in which a fluorescent
reporter was expressed by neuronal precursors and subsequently used to track axonal
growth as the OSNs matured. Our results show that axon extension in both conditions
follow the same timeline. However, markers of synaptic connectivity in the OB were
delayed after injury. The delay in synaptic connectivity was also corroborated with
delays in olfactory behavior after injury, which took 40 days to recover to control levels.
Additionally, we investigated the process of removal of axonal debris created after an
injury. Immunohistochemical analysis after injury indicated upregulation of IBA1+ cells
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within the olfactory nerve layer of the OB, suggesting a role of microglia in this process.
These microglia also showed an activated morphology, and some had very large cell
bodies with multiple nuclei. Furthermore, qPCR analysis of post-injury OB tissue shows
upregulation of the CD11b receptor that is expressed on microglia. Our results have
also shown upregulation of components of the complement pathway after injury, which
is suggestive of a mechanism that underlies axonal debris removal after injury in the
OB. Taken together, these results shed light on the process by which the olfactory
system is able to recover after injury and could lead to discovery of mechanisms that
could translate to treatments for injuries in other areas of the nervous system.
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CHAPTER 1. INTRODUCTION
Transduction of stimuli from the external environment is achieved through our
sensory systems and converted to an electrical signal. The environmental stimuli that
are detected by the olfactory system are volatile elements in the air, commonly referred
to as odors. Odors are detected by neurons in the olfactory epithelium (OE) that line the
nasal cavity. After an odor is detected, the information is transferred from the OE to the
olfactory bulb (OB) in the central nervous system and then subsequently relayed to
higher areas of the brain (DeMaria and Ngai 2010).
The olfactory system has a unique capability for regenerating neurons. The
olfactory sensory neurons (OSNs) that are responsible for the perception of odorant
molecules are constantly dying. It is generally accepted that the high death rate of
OSNs is caused by the exposure of OSNs to the external environment, which is
necessary for the detection of odorant molecules in the air. This makes OSNs unique in
that they are the only neurons in the body that are exposed to the external environment.
However, this additionally exposes the OSNs to toxic elements in the air (e.g. pollution)
that can lead to the death of the neuron. Maintenance of the sense of smell is achieved
by replacing the ever dying OSNs with new neurons derived from the stem cells located
at the base of the OE.
In order to better understand the regenerative process of the olfactory system,
this introduction will first describe the organization of the olfactory system, then we will
introduce the concept of axon guidance and finally, we will describe the process of
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regeneration in the olfactory system both during the events of normal turnover and after
injury.
Organization of the Olfactory System
Aside from the main olfactory system, that will be the focus of this review, the
accessory olfactory system is also located in the nasal cavity. The accessory olfactory
system is comprised of the vomeronasal organ and nerve, and the accessory olfactory
bulb. For additional information on this system, the reader is referred to a recent review
by Mohrhardt et al (2018). Furthermore, there are two additional systems associated
with the detection of odors that include structures such as the septal organ (organ of
Masera) and the Grüeneberg ganglion that will not be discussed here but the reader is
again referred to a review of these system by Minghong Ma (2010). The main olfactory
system can be divided into two primary components: the main OE and the main OB,
which are the most relevant components to the discussion of OSN regeneration.
Olfactory Epithelium
The OE together with its underlying connective tissue, the lamina propria,
compose the olfactory mucosa. The olfactory mucosa lines the dorsal and caudal
portions of the nasal cavity. The nasal septum that divides both sides of the nasal
cavity, along with the turbinates, delineate the shape of the nasal cavity. The OE is a
pseudostratified epithelium and is, broadly speaking, comprised of three cell types:
OSNs, supporting cells, and basal cells (Farbman 1992). Of these cell types, OSNs
represent the larger population of cells in the OE and are responsible for conduction of
sensory information from the OE to the OB. However, the other cell types also play an
important role in olfaction.
10

OSNs are bipolar neurons that have a cell body contained in the OE and extend
an apical dendrite toward the nasal cavity that ends in a knob from which multiple nonmotile cilia arise. On the opposite side of the OSN cell body, an axon projects into the
lamina propria. The axons of the OSNs converge to form (in humans) cranial nerve I
and later cross the most anterior-basal portion of the skull called the cribriform plate to
enter the OB. After entering the OB, the axons defasciculate and make specific synaptic
contacts (Farbman 1992). The OSNs, as previously discussed, are responsible for the
detection of the volatile odorants in the air and do so by the binding of the odorants to
G-protein coupled receptors known as odorant receptors. While the odorant receptors
are located throughout the entire OSN, receptors expressed on the olfactory cilia are
associated with odor detection. The olfactory cilia extend laterally in the mucosal layer
of the nasal cavity, which allows for larger surface area for the binding of odorants. The
binding of the odorant to the odorant receptor leads to the depolarization of the neuron
and creation of an action potential that travels from the dendrite to the cell body of the
neuron and down the axon to the OB.
Supporting cells can be divided into two biochemically separate cell types:
sustentacular cells and microvillar cells (Schwob and Costanzo 2010). One of the
functional roles of supporting cells includes neuroprotection through detoxification via
the expression of the enzymes cytochrome P450 and Glutathione S-transferase (Gu et
al. 1998; Ling et al. 2004; Whitby-Logan et al. 2004). Additionally, supporting cells have
been shown to play a role in phagocytosis of dead OSN cell bodies in a bulbectomy
injury model (Suzuki et al. 1996).
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Basal cells are a group of stem cells that lie on the basal membrane of the OE
near the juncture of the epithelium and lamina propria. The basal cells can be divided
into two distinct cell types: horizontal basal cells and globose basal cells (Farbman
1992). The differing roles of these two cell types will be discussed further when
addressing the process of regeneration of OSNs.
Olfactory Bulb
The OB is the structure in the CNS in which the axons of the OSNs from the OE
make synaptic contact. The OB is comprised of six distinct layers that contain unique
cell types and/or synaptic networks (Figure 1.1). The first and outermost layer of the OB
is the olfactory nerve layer (ONL), which is primarily composed of axons of OSNs
coming from the OE. In addition, a specialized glial cell type called the olfactory
ensheathing cell (OEC) is present in the ONL and plays a role in the process of axon
guidance. The second layer from the periphery of the OB is the glomerular layer (GL),
which is characterized by circular structures called glomeruli in which the OSNs make
synaptic contact with the projection neurons of the OB. Delineating the glomeruli are a
population of interneurons called periglomerular cells that have dendritic projections that
arborize within a glomerulus. Periglomerular neurons are interneurons that receive
synapses from the OSN axons and establish dendrodendritic synapses with the
projection neurons. The third layer of the OB is called the external plexiform layer (EPL),
where there is a network of dendrodendritic synapses between projection neurons and
granule cells, a second type of interneurons of the OB. In addition, the EPL contains the
cell bodies of tufted cells, one of the two types of projection neurons in the OB. The
fourth layer of the OB is called the mitral cell layer (MCL), which contains the cell bodies
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of the mitral cells, the OB’s second type of projection neuron. The fifth layer of the OB is
the internal plexiform layer (IPL), which contains axons from the projection neurons that
travel through the OB and leave to form the lateral olfactory tract and subsequently
contact higher cortical targets. The sixth layer of the OB is the granule cell layer (GCL)
and contains the cell bodies of the granule cells mentioned earlier (Greer et al. 2008).
Additionally, deep in the GCL is the rostral migratory stream (RMS), a mass of newly
born migrating neurons born in the subependymal zone of the lateral ventricle. After
entering the OB, they detach from the RMS and migrate laterally within the OB and
differentiate into new interneurons (both periglomerular and granule cells). The process
and function of the RMS will not be discussed in this review, but the reader is referred to
reviews that discuss the RMS in great detail (Whitman and Greer 2009; Hardy and
Saghatelyan 2017).
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Figure 1.1. DAPI staining showing the different layers of the OB. ONL- olfactory nerve
layer; GL- glomerular layer; EPL- external plexiform layer; MCL- mitral cell layer; IPLinternal plexiform layer; GCL- granule cell layer.
Axon Guidance
The process by which OSN axons extend to their specific synaptic targets within
the OB is known as axon guidance and targeting. This extremely precise process has
been extensively studied but is still not well understood due to the extreme complexity
of this process. To understand the complexity that underlies OSN axon extension and
targeting to a specific synaptic target, one must consider the following list of factors.
14

Each OSN expresses only 1 allele (monogenic and monoallelic expression) out of
approximately 1,200 odorant receptors genes, which in mice theoretically results in up
to 2,400 molecularly distinct sub-populations of OSNs (Chess et al. 1994; Serizawa et
al. 2003). OSNs that express the same odorant receptor are intermingled in the OE with
OSNs that express different odorant receptors. Yet, all of the OSN axons expressing the
same odorant receptor converge into 2-3 glomeruli per olfactory bulb (Richard et al.
2010) and each glomerulus is innervated by only axons expressing the same odorant
receptor (Treloar et al. 2002). Finally, OSN axons are randomly mixed as they navigate
from the OE to the OB and convergence of axons expressing the same odorant
receptor seems to occur proximal to their targeted glomerulus (Ressler et al. 1993;
Miyamichi et al. 2005). With these factors considered, the precision by which axons
extend and reach their synaptic target is truly remarkable. Many molecules and
signaling pathways have been identified that seem to play a role in the extension of
OSN axons and the guidance toward their synaptic targets. The following contains a
brief exploration of a few of the factors that have been implicated in the process of axon
guidance and for more detail on axon guidance molecules in the olfactory system, the
reader is referred to other excellent reviews (Treloar et al. 2001; Mombaerts 2006;
Takeuchi and Sakano 2014).
Epithelial Zone and Glomerular Position
Observations have long been made using retrograde tracing studies that suggest
that OSNs located in given areas of the OE project to a correlating area within the OB
(Astic and Saucier 1986; Pedersen et al. 1986; Schoenfeld et al. 1994; Levai et al.
2003). One study using DiI tracing demonstrated that the position of the glomeruli within
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the OB along the dorsal/ventral axis correlated with a dorsomedial/ventrolateral axis
within the OE (Miyamichi et al. 2005). These observations suggested a zonal map
within the OE that correlates with the glomerular map of the OB. The classic model of
odorant receptor expression in the OE indicated that there were four distinct zones
comprised of OSNs that expressed a limited number of odorant receptors largely unique
from that of the other zones (Ressler et al. 1993; Vassar et al. 1993). However, it has
since been shown that these zones overlap in odorant receptor expression (Norlin et al.
2001; Iwema et al. 2004; Miyamichi et al. 2005). While these zones may not have well
defined borders with regards to odorant receptor expression, there have been
correlations with specific zonal expression of different molecules implicated in axon
guidance. The cell adhesion molecules RNCAM (neural cell adhesion molecule 2) and
OCAM (olfactory cell adhesion molecule) have shown specific zonal expression in
ventral zones 2-4 (Cremer et al. 1994; Alenius and Bohm 1997; Yoshihara et al. 1997).
In accordance with this zonal distribution of axon guidance factors, it has recently been
shown that transplantation of stem cells from the dorsal OE to the ventral OE leads to
an upregulation of OCAM and downregulation of NQO1 (NAD(P)H Quinone
Dehydrogenase 1), a dorsal OSN marker, suggesting that spatial cues present in the
OE determine OSN identity and subsequently their glomerular target (Coleman et al.
2019).
Odorant Receptors
There is a general consensus that odorant receptors are necessary but not
sufficient to fully account for the targeting of the OSN axons to their specific glomerulus
(Wang et al. 1998; Feinstein et al. 2004; Feinstein and Mombaerts 2004). As an
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example of this, it has been shown that OSN axons in mice lacking functional odorant
receptors still extend broadly to the correct area of the OB (Feinstein and Mombaerts
2004). This suggests that axonal navigation from the OE to the OB remains mostly
unaffected by the odorant receptors. However, the function of odorant receptor
expression seems to be more critical for the final targeting of a specific glomerulus
within the OB. In support of this, we have recently shown that odorant receptor
expression does not occur until after the olfactory sensory neuron axons have reached
the OB (Rodriguez-Gil et al. 2015). Our findings suggest a model of OSN axon
extension in two phases: an odorant receptor-independent phase from the OE to the OB
and then an odorant receptor-dependent phase within to the OB to the specific
glomerulus for each odorant receptor.
There are approximately 3600 glomeruli in each OB (Richard et al. 2010) and, as
previously mentioned, this results in an average of 2-3 glomeruli in each OB for every
odorant receptor gene. Glomerular location within the OB can be altered by even small
changes in the gene encoding the odorant receptor and can shift targeting to
adjacent/ectopic glomeruli (Gogos et al. 2000; Strotmann et al. 2000; Feinstein et al.
2004; Feinstein and Mombaerts 2004). Thus, the identity of the odorant receptor is key
in determining the glomerular location within the olfactory bulb rather than an assigned
location via other signaling mechanisms. However, it is noteworthy that this is not an
inherent characteristic unique to odorant receptors. Replacement of the protein coding
region of an odorant receptor locus with that of the β2 adrenergic receptor results in
axons targeting a new glomerulus unique to this receptor (Feinstein et al. 2004). So,
while the receptor expressed in the OSN axons are critical for determining the
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glomerular location within the OB, the mechanisms by which the receptor determines
this location is still not well understood. Downstream signaling through the second
messenger cAMP is important in determining the final position of the axon targeting
(Imai et al. 2006; Chesler et al. 2007). Recently, however, phosphatidylethanolaminebinding protein 1 (PEBP1), a putative binding target for odorant receptors expressed in
the axon terminal, is associated with formation of the OB’s sensory map, and deletion of
PEPB1 leads to an altered glomerular map (Zamparo et al. 2019). These findings could
shed light on the mechanisms that underlie odorant receptor’s role in axon guidance.
Other Molecules of Axon Guidance
In addition to odorant receptors, other mechanisms, including both attractive and
repulsive cues, have been implicated in olfactory sensory neuron axon targeting
(Treloar et al. 2001; Mombaerts 2006; Schwarting and Henion 2008). Several
laboratories have described the spatio-temporal distribution of laminin, tenascin,
semaphorins-neuropilins, cell surface markers and different carbohydrates, and
correlated these observations with the formation and maturation of olfactory bulb
glomeruli (Ring et al. 1997; Kafitz and Greer 1998; Crandall et al. 2000; Pays and
Schwarting 2000; Williams-Hogarth et al. 2000; St John and Key 2001; Treloar et al.
2001; B.W. Lipscomb et al. 2002; B. Lipscomb et al. 2002; Walz et al. 2002; Henion et
al. 2005; St John et al. 2006). Other candidate molecules characterized in the olfactory
system include ephrins/Ephs, robos/slits, netrins/DCC, and Wnt/Frizzled (Astic et al.
2002; St. John et al. 2002; Marillat et al. 2002; Zaghetto et al. 2007; Booker-Dwyer et al.
2008; Rodriguez-Gil and Greer 2008; Wang et al. 2008). As an example, the
dorsal/ventral axis navigation of the OB has been shown to be influenced by expression

18

of Robo2/Slit1 (Cho et al. 2007; Cho et al. 2012) and Nrp2/Sema3F (Takahashi et al.
2010; Takeuchi et al. 2010). When examining the anterior/posterior glomerular location,
Nrp1/PlxnA1 have been shown to have an inverse gradient from anterior to posterior
and changes in their protein levels can alter the anterior/posterior location of a given
glomeruli (Satoda et al. 1995; Imai et al. 2006; Nakashima et al. 2013). Nevertheless,
the full repertoire of mechanisms that influence olfactory sensory neuron axon targeting
remains topical and controversial (Mombaerts 2006; Schwarting and Henion 2008).
Cellular Contributions to Axon Guidance
An OSN axon interacts with several cell types between the OE and its glomerular
target within the OB, which include both glial and neuronal cells. Neuronal cells within
the OB with which the axons make synaptic contact include projection neurons and
interneurons. However, using two targeted genetic deletions targeting each of these
neuronal types, showed that OSN axons still coalesce in their normal glomerular
location (Bulfone et al. 1998). This would indicate that signals from these neurons would
not be a factor in axonal targeting and thus these cells do not contribute to convergence
of the axons expressing one type of odorant receptor in the OB.
While the neurons in the OB appear to have seemingly no role in axon guidance,
another cell type that interacts with the axons is believed to have a key role in axon
extension: the olfactory ensheathing cell (OEC) (Ramón-Cueto and Avila 1998; MorenoFlores et al. 2002; Barraud et al. 2013; Gómez et al. 2018). OECs are specialized glial
cells that wrap around nerve fibers containing the axons of the OSNs both in the lamina
propria and the ONL of the OB. The OEC is a unique glial cell type in that it has
characteristics of both peripheral Schwann cells and central astrocytes while still having
19

their own unique properties (Vincent, Taylor, et al. 2005). OECs are known to express
and secrete multiple factors both in vivo and in vitro that have implications in axon
guidance.
Two markers of OECs that can be seen in the lamina propria and distributed
throughout the ONL are S100β (Franceschini and Barnett 1996; Au et al. 2002) and
brain lipid binding protein (BLBP) (Rodriguez-Gil and Greer 2008), of which the former
has been shown to be important for survival and axon extension (Van Eldik et al. 1991;
Bhattacharyya et al. 1992; Li et al. 1998). Additionally, S100β has been shown to
increase levels of amyloid precursor protein, which is another molecule that promotes
outgrowth of neurites (Li et al. 1998; Moreno-Flores et al. 2003). An additional marker
found expressed at low levels in OECs is glial fibrillary acidic protein (GFAP) (Barber
and Lindsay 1982; Barber and Dahl 1987; Pixley 1992). GFAP is a component of
intermediate filaments that is classically associated with astrocytes with which OECs do
share some characteristics (Vincent, Taylor, et al. 2005). As it has been shown for
astrocytes, increased levels of GFAP are detected in OECs after injury (Barber and
Dahl 1987). While there are some OEC markers that seemingly are ubiquitously
expressed, OECs are not a homozygous cell type in that they express distinct molecular
markers that can divide the OECs into subpopulations both in vitro and in vivo.
In line with OECs sharing characteristics of both Schwann cells and astrocytes,
OECs have been shown to take on the morphology of one of these two cell types when
cultured in vitro. The astrocyte-like OECs show fibrous expression of GFAP as well as
the embryonic, or polysialylated (PSA) form of the neural cell adhesion molecule (ENCAM) in vitro. The Schwann-cell-like OECs show lower intensity of diffuse GFAP and
20

no E-CAM in vitro but also show expression of the low-affinity p75 neurotrophin receptor
(p75NTR) (Pixley 1992; Franceschini and Barnett 1996). Additionally, molecularly
unique OECs can be seen in vivo depending on both the differentiation stage as well as
the location of the OEC (Vincent, West, et al. 2005). Distinct molecular markers of inner
and outer ONL have been described and could indicate different functions of OECs in
these two areas of the OB. Neuropeptide Y has been observed to be expressed by
OECs, with a greater intensity in the inner ONL (Ubink et al. 1994; Ubink and Hökfelt
2000). The expression of neuropeptide Y by OECs would further support a role in axon
guidance by OECs as neuropeptide Y has been shown to increase neurite growth as
well as to be an attractive cue (White and Mansfield 1996; White 1998; Hökfelt et al.
2008). OECs in the outer ONL are reported to express multiple markers that contrast it
from the inner ONL and have been shown to play a role in neurite outgrowth. These
include L1, E-NCAM, p75NTR, laminin, fibronectin, type IV collagen, and amyloid
precursor protein (Miragall et al. 1988; Miragall et al. 1989; Seki and Arai 1993;
Doucette 1996; Kafitz and Greer 1997; Kafitz and Greer 1999; Au and Roskams 2003;
Moreno-Flores et al. 2003; Gehler et al. 2004; Bonfanti 2006).
An additional glial cell type that the OSNs axons encounter are microglia.
Microglia are considered the resident immune cell of the brain and not well studied with
relation to axon growth. However, there has been recent work that has shown microglia
associated with developing axonal tracts (Pont-Lezica et al. 2014). Furthermore,
depletion of microglia using genetic approaches inhibited outgrowth of dopaminergic
axons in the developing mouse forebrain (Squarzoni et al. 2014). At this time, the
contribution of microglia to axon guidance in the olfactory system has not been
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described. However, microglia within the OB have been shown to play a role in synaptic
pruning (Reshef et al. 2017; Wallace et al. 2020). Additionally, microglia have been
reported to secrete neurotrophic factors and that they may play an indirect role in axon
extension via modulation of PI3-K (Reemst et al. 2016).
Regeneration in the Olfactory System
Neurogenesis, or generation of newly born neurons from neural stem cells, is an
area of continual research. It was long thought that the neurons that are present at birth
are the only neurons present throughout life and no regeneration of neural cells
occurred. However, it has since been shown that neurogenesis occurs in two different
areas within the central nervous system: the subventricular zone and the dentate gyrus
of the hippocampus (Kaplan and Hinds 1977; Luskin 1993; Kuhn et al. 1996; Doetsch et
al. 1999). As previously mentioned, the subventricular zone is the source of
neurogenesis that originates the rostral migratory stream, which leads to new
interneurons within the OB (Whitman and Greer 2009). An additional source of
neurogenesis within the olfactory system occurs within the OE and is critical for
maintenance of the olfactory sense. Neurogenesis within the OE begins during
embryonic development. After birth, neurogenesis within the OE progresses into a
period of postnatal expansion before finally entering into a time of adult maintenance
that continues throughout life (Murdoch and Roskams 2007).
Sensory Neuron Regeneration in the Olfactory Epithelium
OSNs have a high turnover resulting in an average lifespan of approximately 1
month. However, some OSNs can live from 3-12 months (Deckner et al. 1997). A
contribution to the high turnover rate is OSNs at all stages of differentiation, including
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neural progenitor, immature, and mature OSN stages, undergo regular apoptosis in the
mouse OE in a way that is believed to be a way to control the number of OSNs in the
OE (Holcomb et al. 1995). Another contribution to the high turnover of OSNs is their
exposure to the external environment in order to detect odorant molecules, which
exposes the OSNs to potentially harmful elements (Ashwell 2012). The constant death
of OSNs is counteracted by the continual neurogenesis that generates new OSNs. It is
believed that the programmed cell death of OSNs and neurogenesis in the OE occurs
throughout life. However, it has been shown that both apoptosis and proliferation
decrease with age in the OE (Fung et al. 1997). In conflict with this report, an increase
in apoptotic markers has been observed in the aged (24 month) rat OE (Robinson et al.
2002), which could play a role in age-related loss in olfaction. Additionally, it has been
reported that the basal cells that are responsible for OE neurogenesis can become
exhausted in both humans and in mice, which could further contribute to decreased
neurogenesis and loss of the olfactory sense with age (Largent et al. 1993; Holbrook et
al. 2005).
Horizontal vs Globose Basal Cells. A critical component of the regenerative
capacity of the olfactory system are the basal cells in the OE that act as the progenitors
for regeneration of the cells within the OE. In addition to regenerating OSNs, the basal
cells can replenish non-neuronal cell types within the OE (Chen et al. 2004). As
mentioned earlier, the basal cells can be divided into two categories: horizontal basal
cells (HBCs) and the globose basal cells (GBCs). These two basal cell types are
candidate stem cells and differ in that GBCs are actively proliferating while HBCs are
largely quiescent (Mackay-Sim and Kittel 1991). The concurrence of proliferating and
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quiescent stem cells has been reported in other systems and is thought to play a key
role in maintenance of these systems (Linheng and Clevers 2010).
Tissue stem cells have shared characteristics in that they are self-renewing,
quiescent under normal conditions, and totipotent with respect to the tissue in which the
stem cells are located (Pevny and Rao 2003; Schwob and Costanzo 2010). Within the
OE, the HBCs seem to meet these requirements and thus could be considered the stem
cells of the OE. HBCs appear to remain quiescent outside of an injury in which GBCs
are destroyed and then HBCs can transiently proliferate to create new GBCs to
regenerate the OE (Leung et al. 2007).
Lineage tracing studies have shown that GBCs are the direct progenitors of
newly born neurons in the OE (Caggiano et al. 1994). In support of this, an area of the
OE that is depleted of GBCs and suffers an injury will be reconstituted into respiratory
epithelium, further demonstrating that GBCs are required for the regeneration of OSNs
(Jang et al. 2003). Initially, GBCs were characterized by the absence of staining with
markers that identified other cell types such as the HBC or OSN (Goldstein and Schwob
1996). Since that time, much has been learned about the GBC and is now believed to
exist in multiple stages of differentiation and division state (Schwob and Costanzo
2010). One of these stages include a tentative stem cell state that appears to remain in
a quiescent state, much like the HBCs (Jang et al. 2014). A second stage is the
transient amplifying stage in which the GBCs divide to create a second GBC for selfrenewal and then a second cell that will act as the immediate neuronal precursor (INP).
Upon reaching the INP stage, the GBC is committed to the pathway of differentiation
into an OSN (Huard et al. 1998).
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Neuronal Differentiation and Axon Extension. The neural lineage of OSNs enters
the INP phase after dividing from a transient amplifying GBC. The INP phase can be
divided into two stages of which can be characterized by the expression of neuronal
differentiation promoting transcription factors such as Ascl1 (Achaete-scute homolog 1
or Mash1) and neurgenin1 (Cau et al. 2002). Subsequent to the stages in which these
transcription factors are expressed, the INP will undergo further differentiation into an
immature and finally a mature OSN. Immature and mature OSN cell bodies can be
differentiated based on their location within the OE as well as by distinct molecular
markers. Immature OSN cell bodies are generally localized in the lower portion of the
OE just above the basal cell layer as the cell bodies migrate apically during
differentiation. The immature OSNs are characterized by the expression of growthassociated protein 43 (GAP43). As the OSNs further differentiate, their cell bodies
further migrate more apically and will no longer express GAP43 but will now express
olfactory marker protein (OMP), a classical marker of mature OSNs (Rodriguez-Gil et al.
2015; Liberia et al. 2019).
While markers such as GAP43 and OMP have long been used to differentiate
immature and mature neurons within the OE, the process of axon extension after
differentiation from neural progenitors proved more challenging. However, more recent
work using genetic Cre-LoxP models have allowed for the timeline of axonal extension
during OSN maturation to be defined (Rodriguez-Gil et al. 2015; Liberia et al. 2019).
Additionally, this work on the process of OSN differentiation has shown that the onset of
OR expression does not occur until the OSN axons reach the olfactory bulb. This would
suggest that the OSN axon extension occurs in two phases, an OR-independent phase
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from the OE to the OB and an OR-dependent phase within the ONL of the OB to the
glomerulus where the axon makes synaptic contact (Rodriguez-Gil et al. 2015).
Furthermore, comparison of early post-natal and juvenile maturation of OSNs indicated
that the progression of maturation displayed a similar timeline with only small delays in
progression in juvenile subjects (Liberia et al. 2019).
Regeneration after an Olfactory Injury
In addition to OSN regeneration under normal conditions, the olfactory system
also has the unique ability to recover and regenerate after an injury. The capacity of the
OE to regenerate has been significantly studied using different models of an olfactory
injury (Brann and Firestein 2014; Yu and Wu 2017). These injury models have been
used to study physiological and behavioral responses within the olfactory system.
Olfactory Injury Models. A common experimental injury model is the removal of
the OB, or olfactory bulbectomy (OBX). When an early postnatal OBX is performed,
there is retrograde degradation of the OSNs in the OE. Interestingly, though the normal
target tissue of the OSNs is absent, the OSNs extend new axons and form glomeruli
within the cerebral hemisphere that has migrated anteriorly into the position normally
occupied by the OB (Graziadei et al. 1978; Graziadei et al. 1979). However, other
studies looking at cellular dynamics after OBX have shown there is an incomplete
regeneration of the OE (Costanzo and Graziadei 1983) and a decrease in mature OSN
markers (Carr et al. 1998; McIntyre et al. 2010). In spite of the abnormalities associated
with regeneration after OBX, odorant detection and discrimination can occur after the
OBX procedure (Slotnick et al. 2004). The OBX model, while valuable to study cell
regeneration in the OE, may not be suitable for studying axon regeneration because the
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removal of the OB also removes the normal target of the OSNs and therefore the
trophic support from the OB. Furthermore, the OBX model would be problematic in
describing behavioral recovery of olfaction due to the lack of normal CNS structures and
abnormal regeneration. Additionally, OBX has been extensively used as a model to
study depression (Song and Leonard 2005; Morales-Medina et al. 2017), potentially
complicating behavioral analysis in this model.
An additional model of olfactory injury is a manual transection of the OSN axons
between the OB and the cribriform plate (Yee and Costanzo 1995; Yee and Costanzo
1998). Experiments using this axotomy model analyzed a wide range of post-injury time
points. OSN axons have been reported to reach the OB by 35 days after axotomy in a
hamster (Morrison and Costanzo 1995). In mice, recovery of connections assessed by
olfactory marker protein (OMP)-LacZ expression is observed 42 days after lesion
(Kobayashi and Costanzo 2009) and OMP-expressing axons begin to innervate the
glomeruli as early as 25 days after surgery (Graziadei and Monti Graziadei 1980). Some
of the differences observed in these results could be accounted for variations in the
efficiency of the nerve transection. Olfactory behavior also appears to recover around
35 days after axotomy as this is when a response to odorant stimuli in hamsters can be
observed (Costanzo 1985). Furthermore, a recovery of olfactory detection and
discrimination has been shown at 40 days post axotomy (Yee and Costanzo 1995; Yee
and Costanzo 1998) but the discriminatory tasks do require additional reinforcement in
order for injured animals to relearn (Yee and Costanzo 1998).
Finally, the last model to study insult-related regeneration is chemical ablation via
administration of olfactotoxic agents that produces seemingly selective damage to the
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olfactory epithelium. These treatments include multiple compounds and methods of
delivery. The first example of these chemical ablation injuries is a nasal lavage
administration of Zinc Sulfate (ZnSO4) and Triton X-100 (Baker et al. 1983; Burd 1993).
A second method of inducing a chemical ablation injury is via inhalation of methyl
bromide (MeBr) gas (Schwob et al. 1995). Finally, the third approach to induction of a
chemical ablation is via injection of chemicals such as dichlobenil or methimazole
(Brandt et al. 1990; Genter et al. 1995). An advantage of chemical lesions is that the
target, the olfactory bulb, remains intact, and only the cells in the olfactory epithelium
are lost, followed by a rapid proliferation of the basally located stem cells (Hurtt et al.
1988; Genter et al. 1995; Williams et al. 2004). This makes the chemical ablation an
ideal approach to carefully study events of axon regeneration and extension.
Cellular Dynamics after an Olfactory Injury. Studies of cellular dynamics in the
olfactory epithelium after methimazole administration have shown onset of beta-tubulin
III (a marker of immature OSNs) expression 4 days after lesion, and OMP at 7 days
(Suzukawa et al. 2011). An additional study using the methimazole injury model showed
small numbers of OMP-expressing cells 5 days after injury followed by gradual
increases at 8, 15 and 22 days post-injury (Ogawa et al. 2014). Using a transgenic
mouse model in which LacZ is co-expressed with the odorant receptor M72, it has been
shown that there are only a few M72-expressing cells 10 days after methimazole
injection. By 25 days post-injury, the number of M72-LacZ cells significantly increased in
the epithelium and was recovered to control levels by 45 days (Blanco-Hernández et al.
2012).
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Axonal Debris Removal
It is estimated that humans turnover as much as 300 billion cells every day
(Arandjelovic and Ravichandran 2015). In the central nervous system, approximately
50% of the generated neurons experience apoptosis during development (Burek and
Oppenheim 1996). With such a huge turnover of cells and creation of cellular debris
after cell death, mechanisms for clearance of debris must exist for cellular systems to
function properly. Furthermore, the suppression of the inflammatory response has been
demonstrated to result from the clearance of apoptotic cells (Huynh et al. 2002).
Clearance of neuronal debris is thought to be essential for suppressing inflammation,
keeping a healthy neuronal environment, and helping in recovery of function (Neumann
et al. 2009). Several neurodegenerative diseases, such as Alzheimer’s and Parkinson’s
disease, present an inflammatory component that is characterized by the activation of
microglia (Wang et al. 2015; Schain and Kreisl 2017).
Due to the constant turnover of OSNs, debris from the dying neurons in both the
OE and the OB is constantly being generated. The process by which this debris is
removed in the OE and OB is not well understood. The cells that act as the phagocytes
in the olfactory system and the molecular pathways by which engulfment of this debris
occurs has not been fully characterized. Additionally, it is not well known if this process
differs after an injury when compared to normal regeneration.
Cellular Phagocytosis. In the primary olfactory pathway, the evidence for the cell
type responsible for removing axonal debris is inconclusive. Despite some evidence of
OECs removing debris, other evidence points to microglia and or macrophage
infiltration being responsible for the clearance of neuronal debris. Cultured OECs have
29

the ability to engulf apoptotic neurons (Su et al. 2013). Furthermore, during early
development of a mouse, OECs have been shown to be responsible for clearing the
degenerating axons (Nazareth et al. 2015). On the other hand, microglia have been
reported in the olfactory nerve (Smithson and Kawaja 2010) and have also recently
been associated with the refinement of connections in the olfactory bulb ((Lehmann et
al., 2018) not peer reviewed). Furthermore, in a study using the Triton X-100 nasal
lavage injury model followed by infection with Staphylococcus aureus, Iba1+ cell
(common marker of macrophage and microglia) infiltration was observed in both the OE
and the OB and seem to be in an activated phenotype based on coexpression of iNOS
(Herbert et al. 2012). However, it is difficult to distinguish if the infiltration and activation
of Iba1+ cells in this study is due to the olfactory lesion or the bacterial challenge. Yet, it
is important to note that microglia/macrophages can respond to an insult of the olfactory
system.
Molecular Mechanisms of Phagocytosis. The process of phagocytosis has three
different types of signals that have been described: find-me, eat-me, and digest-me
signals (Sierra et al. 2013). Find-me signals have been shown to involve the release of
ATP and UTP from dead cells in order to recruit phagocytes to the site (Honda et al.
2001; Davalos et al. 2005; Koizumi et al. 2007). Eat-me signals can be subdivided into
two processes: tethering and engulfing (Sierra et al. 2013). Tethering involves the
recognition of apoptotic cells through signals such as exposed phosphatidylserine,
which is normally only located in the inner leaflet of the phospholipid bilayer of the cell
membrane but can be exposed after a cell undergoes apoptosis (Fadok et al. 1992;
Fadok et al. 2000). The engulfment process is mediated but multiple different receptors
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and pathways that signal the internalization of apoptotic cells and debris (Sierra et al.
2013; Brown and Neher 2014; Vilalta and Brown 2018). Finally, digest-me signals are
involved in the maturation of the phagosome and degradation of phagocytosed
materials (Desjardins et al. 1994; Garin et al. 2001).
Within the central nervous system, phagocytic signals have been studied largely
in microglia. Processes of microglia have been shown to be dynamic in their
movements in a way that is suggested to be a surveillance of their environment
(Nimmerjahn et al. 2005). This surveillance by microglia can lead to a response to areas
of injury or apoptotic cells via known find-me signals, such as ATP and fractalkine
(Davalos et al. 2005; Noda et al. 2011). Response to the fractalkine signal can lead to
the release of milk fat globule EGF factor 8, which can bind to phosphatidyl serine on
apoptotic cells and debris and act as an opsonin for the tethering of the microglia via
integrin RGD motifs (Leonardi-essmann et al. 2005; Fuller and Van Eldik 2008; Fricker
et al. 2012). Multiple pathways for engulfment in microglia have been identified. These
pathways include engulfment by a complement mechanism that has been shown to play
a role in retinal synaptic pruning in vivo and neurite engulfment in vitro (Linnartz et al.
2012; Schafer et al. 2012). Additionally, receptors in the TAM (Tyro3, Axl, MERTK)
family have been shown to be involved in microglial phagocytosis (Grommes et al.
2008; Fourgeaud et al. 2016). The digest-me signals in microglia are not well
understood, but have been observed in invertebrates that microglia require ATPase
activity in the phagolysosome in order for neuronal debris to be degraded (Peri and
Nüsslein-Volhard 2008).

31

Knowledge of phagocytic mechanisms within the olfactory system is limited. Most
of our knowledge of axon removal in this sensory system after degeneration comes
from invertebrates. Drosophila melanogaster OECs express components of the Draper
engulfment signaling pathway and that these are essential for the clearance of sensory
neuron axons that degenerated (Doherty et al. 2009; Doherty et al. 2014; Musashe et
al. 2016). Homologs to the Draper pathway mediate, at least in part, phagocytosis in the
mammalian peripheral nervous system where glial cell precursors clear debris from
apoptotic cells via the receptors Jedi-1 (mammalian homolog of Draper) and MEGF-10
(Wu et al. 2009). Additional proteins required for the engulfment process have been
described, such as the adaptor protein CED-6 in Caenorhabditis elegans, which
recently was shown in vitro that its mammalian homologue, GULP, is also required for
engulfment (Sullivan et al. 2014). However, neither these engulfment proteins that are
seemingly expressed in OECs nor mechanisms underlying microglial phagocytosis have
been studied in the mammalian olfactory system.
Discussion
The regenerative capability of the olfactory system is quite remarkable in that it
able to maintain an extremely complicated neural network intact despite the high
turnover rate of OSNs. Furthermore, the ability to recover from a devastating injury to
the OE is unmatched in other areas of the nervous system. Despite learning a great
deal about regeneration in the olfactory system, the underlying mechanisms are still not
well understood. There are still many fundamental questions that need to be answered,
which include the following: What is the mechanism underlying OR selection and how is
only one allele of all possible ORs expressed? What are the mechanisms by which OSN

32

axons extend from the OE to the OB and within the OB to target their specific synaptic
target? What are the mechanisms by which OECs promote axon extension and how
can this translate to therapeutic treatments in other systems? What are the cellular and
molecular mechanisms by which axonal debris is removed in the olfactory system that
seems to avoid a chronic inflammatory state? How is the synaptic system of the
olfactory system restored functionally and anatomically after a complete ablation injury
that destroys nearly all OSNs? Understanding these fundamental questions underlying
the regenerative capability of the olfactory system will provide a wealth of knowledge
into the ability of a neural system to regenerate and can provide powerful insight into
mechanisms that could be applied to other neuronal systems.
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CHAPTER 2. AXON EXTENSION AFTER METHIMAZOLE-INDUCED INJURY
EMULATES NORMAL REGENERATION BUT DISPLAYS A DELAY IN
SYNAPTOGENESIS
Rudy T. Chapman, Lea N. Lance, Russell W. Brown, and Diego J. Rodriguez-Gil
Abstract
The regenerative capability found in the olfactory system is of great interest in
research. Basal cells in the olfactory epithelium generate new olfactory sensory neurons
throughout life during both normal regeneration and after an injury. In order to study
axonal regrowth after a chemical ablation injury, a fate-mapping technique utilizing an
inducible Cre-ERT2 model labeling newly born olfactory sensory neurons was used.
Fate-tracing experiments demonstrated that newly generated olfactory sensory neurons
after chemical ablation extend axons that reach the olfactory bulb and extend to the
glomeruli in a timeline that is similar to that seen in normal regeneration. In addition,
functional recovery of the olfactory system, as indicated by the ability of mice to find a
hidden cookie after methimazole injection, suggest that recovery takes 40 days. On a
histo-anatomical level, the newly born olfactory sensory neurons display a similar rate of
maturation post-injury when compared to normal regeneration, as evidenced by coexpression of olfactory marker protein with the fluorescent reporter. However, levels of
markers associated with synaptic vesicles in the glomeruli of the OB suggest that
recovery of the synaptic connectivity may not be complete until 40 days post-injury. In
conclusion, while olfactory sensory neuron axonal extension to the olfactory bulb follows
a similar timeline to that seen in normal regeneration, behavioral and histo-anatomical
data suggest that there is a delay of 40 days in recovery of the olfactory neural network.
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Introduction
Olfactory sensory neurons (OSNs) are the cells within the olfactory epithelium
(OE) that are responsible for the detection of odorants. In order to detect odorant
molecules, the OSNs must be partially exposed to the external environment in the nasal
cavity, which can lead to the exposure of harmful elements and subsequent death of the
OSN (Farbman 1990). This continuous loss of neurons is counterweighed by an
ongoing neurogenesis. There is a population of stem cells at the base of the OE that
can generate new cells throughout life to populate the OE, including OSNs (Brann and
Firestein 2014). Therefore, the sense of smell is maintained despite the high death rate
of OSNs due to the counteraction of cell loss via neurogenesis from the basal stem
cells. In addition to the normal regeneration that takes place, the OE is capable of
recovering from severe lesion injuries. After an injury, the basal stem cells can produce
an OE that is both structurally (Schwob et al. 1995; Schwob et al. 1999) and functionally
(Blanco-Hernández et al. 2012) similar to that of the pre-injury OE.
After a new neuron is born during either normal regeneration or after injury, it
must extend an axon from the OE to the olfactory bulb (OB). In our previous work, we
established the time course for axon extension during normal regeneration (RodriguezGil et al. 2015) using a transgenic fate-mapping strategy. Nevertheless, data are scarce
on neuron regeneration and axon extension when the olfactory system suffers a major
injury. Our transgenic mouse model provides us an excellent tool to trace axon
extension and therefore we decided to use it to understand injury-induced regeneration.
Multiple injury models of the olfactory system have been employed and have shown
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varying results. Transection of the olfactory nerve has shown a large variance in
reinnervation of olfactory axons (Graziadei and Monti Graziadei 1980; Kobayashi and
Costanzo 2009), which could be attributed to the efficiency of the transection. OB
removal is another model used to study regeneration (Carr et al. 1998; McIntyre et al.
2010) but this removes the target of the newly growing axons and is therefore not suited
for the study of axon extension. The last approach we considered was chemical ablation
using olfactotoxic agents which can be delivered via nasal lavage, inhalation, or
injection (Hurtt et al. 1988; Genter et al. 1995; Williams et al. 2004). The chemical
ablation model is advantageous as the target, the OB, remains intact and only the cells
of the epithelium are removed apart from the basal stem cells, which begin to rapidly
proliferate after injury. We chose to use a chemical ablation model, specifically an
intraperitoneal injection of methimazole, in our study of axon extension after injury
because of its reproducibility. In this study, we use our developed Cre-LoxP model
(Rodriguez-Gil et al. 2015) to show the extension of axons from the OE to the OB, and
correlate this with behavior and synaptic connectivity after a methimazole-induced
injury.
Materials and Methods
Animals
Ascl1tm1.1 (Cre/ERT2)Jejo/J mice (The Jackson Laboratory: stock# 012882)
were crossed with either B6.Cg-Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze/J reporter
mice (The Jackson Laboratory: stock# 007906) or B6.Cg-Gt(ROSA)26Sortm14(CAGtdTomato)Hze/J (The Jackson Laboratory: stock# 007914) (Figure 2.1A). The use of
either reporter strain gave undistinguishable results under a double-blind analysis and
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the fluorescent reporter will subsequently be referred to as XFP as both reporter strains
were used. Pups from these crosses were divided into two groups: some were treated
at postnatal day (PND) 7 while others were allowed to age to 3-months-old. At their
corresponding age, each animal received an intraperitoneal (IP) injection with either
saline or methimazole (75 mg/kg, Sigma-Adrich: Cat# 46429). Pups that were
heterozygous for both Ascl1 driven Cre-ERT2 and the fluorescent reporter (ZsGreen or
TdTomato) were used for neuronal fate-mapping experiments. Littermates negative for
the Ascl1 driven Cre-ERT2 were used for characterization of expression of other
neuronal and synaptic markers post-injury. Double heterozygous pups received an IP
injection 24 hours after saline or methimazole (at PND 8) with 4HO-tamoxifen (40
mg/kg, Sigma: Cat# H6278) or sunflower oil. In 24 hour increments post-injection, mice
were anesthetized and transcardially perfused with PBS with 1 unit/mL of heparin,
followed by 4% (wt/vol) paraformaldehyde (PFA) in PBS at 4°C. Tissue remained in 4%
PFA overnight at 4°C for post-fixation and was then transferred to PBS. The tissue was
then decalcified and then embedded in OCT compound and kept at −80 °C until use.
Tissue collection times ranged from 2 to 40 days post saline/methimazole injection (1 to
10 days post 4HO-tamoxifen injection for axonal fate-mapping experiment; Figure 2.1B).
All procedures were performed in accordance with the National Institute of Health Guide
for the Care and Use of Laboratory Animals and were approved by the Institutional
Animal Care and Usage Committee of East Tennessee State University.
Immunohistochemistry
Tissue sections were collected at 20 µm and stored at -20°C until use. On the
day of use, the tissue sections were treated with blocking solution, 2% bovine serum
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albumin in PBS with 0.3% Triton X-100 (PBS-T) for 1-2 hours at room temperature. The
slides were then incubated with primary antibodies diluted in the same blocking solution
and left in a humidified chamber at 4°C for 1-2 nights. Primary antibodies and their
dilutions were as follows: rabbit anti-ZsGreen (1:300, Clontech: Cat# 632474), goat antiTdTomato (1:1000, Acris: Cat# AB8181-20), goat anti-OMP (1:2000, Wako: Cat# 54410001), rabbit anti-TH (1:1000, Millipore: Cat# AB152), mouse anti-synaptophysin
(1:1000, Chemicon Int: Cat# MAB329) mouse anti-VGlut1 (1/50, Synaptic Systems:
Cat# 135 511), and rabbit anti-VGlut2 (1/200, Synaptic Systems: 135 403) . After
incubation with primary antibodies, tissues were washed with PBS-T. Tissue was then
incubated with secondary antibodies conjugated to Alexa Fluor and DAPI (1:1000) in a
humidified chamber for 1-2 hours at room temperature. After this, tissue sections were
washed with PBS-T and then PBS. Slides were covered with Fluoro-Gel mounting
medium (EMS: Cat# 17985-11) and coverslipped. Images were acquired using an
Olympus BX41 fluorescent microscope or a Leica SP6 confocal microscope.
Image Quantification
Measurement of olfactory marker protein (OMP) and XFP colocalization was
done using the colocalization plugin for ImageJ software. The colocalized area within
the olfactory epithelium was quantified and expressed as the area of colocalization
divided by the total area of XFP staining within the OE. This procedure was performed
on tissue collected on 8-10 and 21-days post 4HO-tamoxifen injection and 9-11 and 22
days after either methimazole or saline injection to compare the expression of OMP in
newly born neurons after injury with normal regeneration.
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Immunofluorescent staining of OB tissue collected 2-, 7-, 14- and 40-days post
methimazole or age matched controls was performed for tyrosine hydroxylase (TH),
synaptophysin, vesicular glutamate transporter (VGlut) 1, and VGlut2 as described
above. Images were captured using a fluorescent microscope and analyzed using
ImageJ software. In order to minimize differences in between experiments and samples,
the level of fluorescence detected in the ONL was used to normalize background signal.
After background fluorescence correction of each image, the mean fluorescence of TH,
synaptophysin, VGlut1 and VGlut2 were detected within the glomeruli and quantified.
Hidden Cookie Test
3-month-old mice were used for assessment of their ability to find a hidden
cookie after injury. Mice received either an intraperitoneal injection of methimazole (75
mg/kg) or saline and were tested at 3-, 14-, 21-, or 40-days post injection. Mice were
fasted for 23 hours prior to testing. Mice were then placed in a 46 cm L X 23.5 cm W X
20 cm H cage with 5 cm of bedding and allowed to habituate for 10 minutes. After
habituation, the mice were removed, and a cookie was hidden under the bedding. The
mice were then placed in the center of the cage and the latency to find the cookie were
recorded. The maximum time allowed to find the cookie was 15 minutes and a time of
900s was assigned when a mouse failed to find the cookie. Additionally, a double-blind
analysis was performed to determine the latency to the target zone surrounding the
cookie. The first occurrence of a mouse entering the area of the hidden cookie and
remaining for a minimum of two seconds to rule out chance crossings was ruled as a
positive entrance. Saline-injected controls run at 3-, 14-, 21-, and 40-days post injection
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were found to have no significant difference in latency to find the cookie and were
grouped together in the final analysis.
Statistics
A Shapiro-Wilk normality test analysis of the behavioral and synaptic vesicle
imaging numbers showed that the data was not normally distributed and therefore nonparametric statistical analyses were performed. Kruskal-Wallis one-way ANOVA was
used to determine if there was a significant difference among multiple groups. For posthoc analysis, Dunn’s multiple-comparison test was used to compare MM-treated groups
versus saline-treated controls. For OMP-XFP colocalization analysis, a two-way ANOVA
was used to compare both injury versus normal regeneration and days post4HOtamoxifen injection as independent variables. Post-hoc analysis using StudentNewman-Keuls test was performed to analyze difference between groups. A significant
difference was indicated by a p-value of less than 0.05. Data is represented as mean ±
SEM.
Results
Regeneration of the Olfactory Epithelium
To determine the best time for the 4HO-tamoxifen (4HO-Tx) injection, we
administered methimazole at PND 7 and then injected 4HO-Tx at 24-, 48-, or 72-hours
after methimazole administration and collected the tissue at PND 12. All three
timepoints analyzed rendered high numbers of labeled OSNs that seemed
undistinguishable from one another (data not shown). Given that we wanted to correlate
axon extension and synapse formation with animal behavior, we selected the earliest
timepoint (24 hours) for induction of the fluorescent marker after methimazole. We first
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set out to determine the temporal profile of injury-induced neuronal regeneration. In
order to do this, we looked at the labeling of OSNs cell bodies in the OE. At the first
timepoint of tissue collection, which was two days post methimazole (2 DPMM) or saline
injection (2 DPsal) and one day post 4HO-Tx injection (1 DPTX), we observed cells
labeled with XFP in both methimazole and saline treatments were located adjacent to
the lamina propria in the most basal portion of the epithelium (Figure 2.1C-D). This was
independent of the marked and expected difference in the thickness of the epithelium
between methimazole- and saline-injected mice. In addition, a portion of the shredded
epithelium could be seen on the apical surface of the newly growing epithelium in many
areas of the olfactory mucosa (Figure 2.1C). Additionally, as previously reported
(Rodriguez-Gil et al. 2015; Liberia et al. 2019), the labeled neurons largely contain
neither apical dendrites nor axons at this point. However, when we looked at labeled
cells at 2 DPTX, we saw a higher rate of extension of apical dendrites and axons
extending from the cell bodies and entering the lamina propria in both saline and
methimazole injected subjects (Figure 2.1E-F). It was noted in methimazole treated
subjects that the extension of the apical dendrites was sometimes horizontal through
the epithelium rather than vertically toward the apical surface of the epithelium as seen
in saline treated subjects. In subsequent days, the neuronal cell bodies migrated
apically toward the nasal cavity (Figure 2.1 G-L). Furthermore, methimazole treated
subjects showed an increase in thickness of their epithelia by 10 DPTX that approaches
that of the saline treated subjects (Figure 2.1 K-L).
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Figure 2.1. Study design and immunofluorescent images showing the labeling of newly
born neurons in the OE in control and methimazole (MM) treated subjects. A: Diagram
of genetic design of CreERT2 driven by Asl1 promoter and either ZsGreen or TdTomato
(represented as XFP) behind the strong CAG promoter and a LoxP flanked stop codon.
B: Diagram showing strategy for injection of MM/Sal and Tx and subsequent tissue
collection. C-D: At 1 DPTX, labeled neurons are located near the basement membrane
of the OE indicated by the solid white line. A piece of shredding OE (indicated by the
dashed line) is seen above the regenerating OE in the MM-injected (A, shown at higher
magnification in the inset). E-F: At 2 DPTX, extension of axons and dendrites from the
newly formed neurons can be seen. Higher magnification to show axons extending from
cell bodies (E inset). G-L: From 5 to10 DPTX we see migration of cell bodies toward the
apical surface of the OE. Additionally, the MM treated subjects show a recovery of the
thickness of the epithelium that nears that of controls by 10 DPTX. (Scale bar: 30µm)

Extension of OSN Axons to the Olfactory Bulb
Next, we analyzed the extension of newly generated OSN axons to the olfactory
bulb. Labeled axons in both methimazole and saline-treated subjects extended in a
manner in which they reached the same landmarks at the same point post- 4HOtamoxifen injection. Labeled axons were first seen crossing the cribriform plate into the
OB at 3 DPTX (Figure 2.2 A-B). In the following days, the fluorescently labeled axons
progressed deeper into the OB with the newly outgrowing axons located primarily in the
outer olfactory nerve layer by 5 DPTX (Figure 2.2 C-D). By 8 DPTX, the axons had
progressed from the outer olfactory nerve layer to the inner olfactory nerve layer and
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had begun to extend into the glomerular layer in the most ventral portion of the OB
(Figure 2.2 E-F). At 10 DPTX, the glomeruli of the most ventral portion of the olfactory
bulb were heavily labeled with fluorescently labeled axons (Figure 2.2 G-H). The time
course of axon extension observed in these experiments is consistent what was
previously reported in a non-injury model of axon extension (Rodriguez-Gil et al. 2015).
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Figure 2.2. Immunofluorescent tracing of labeled OSN axons in control and
methimazole (MM) treated subjects. A-B: At 3 DPTX, labeled axons are first seen
crossing the cribriform plate and entering the ONL of the OB. C-D: At 5 DPTX, axons
are primarily in the outer olfactory nerve layer (oONL). E-F: At 8 DPTX, axons
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encompass the entire ONL and have begun to enter the glomerular layer (GL) (white
arrows). G-H: At 10 DPTX, the axons are heavily present in the glomeruli. (Scale bar:
30µm) OE: olfactory epithelium, CP: cribriform plate, ONL: olfactory nerve layer, oONLouter ONL, iONL- inner ONL, GL- glomerular layer
OMP Expression in Newly Born Neurons of the OE
To assess maturation of the newly born OSNs after injury, the co-expression of
OMP with XFP in OSNs labeled after injury was analyzed and compared to coexpression of OMP and XFP in OSNs labeled during normal regeneration (Figure 2.3).
Control OSNs showed colocalization of OMP and XFP at 8-, 9-, and 10 DPTX but did
not show an increase in their levels of colocalization from 8-10 DPTX. In contrast with
control OSNs, the colocalization of XFP and OMP in MM treated OSNs showed a trend
suggestive of an increase in colocalization between 8-10 DPTX (Figure 2.3B), but
statistical analysis revealed there was no statistical difference between these
timepoints. By 21 DPTX, a larger co-expression of OMP and XFP was seen in both
control and MM-treated OSNs and colocalization at this timepoint was significantly
higher than that seen at 8-, 9-, and 10DPTX (Figure 2.3B). Analysis of interaction
between the independent factors of injury versus normal regeneration and DPTX show
no interaction between these two factors, indicating that MM treatment had no effect on
maturation of newly born OSNs as indicated by co-expression of OMP in the newly born
OSNs.
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Figure 2.3. Colocalization of XFP and OMP in the OE. A. Representative image
showing immunofluorescent staining of the OE with XFP and OMP and the
colocalization of the two markers. B. Quantification of the colocalization analysis
comparing control and methimazole-treated groups. Two-way ANOVA shows that
21DPTX is significantly different from 8-, 9-, and 10DPTX but there is no difference
between MM and control groups. N=3 for each group, * p≤0.05.
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Synaptic Density and Activity in the OB
To investigate changes in synaptic activity and synaptic density after injury,
levels of TH and synaptophysin were analyzed within tissue sections of the olfactory
bulb. TH was used as an indicator of synaptic activity as TH expression in
periglomerular cells is correlated with activity within the glomeruli (Sakai and Nagatsu
1993). Synaptophysin is a protein expressed in synaptic vesicles of the glomerular
layer (GL) and the external plexiform layer (Kasowski et al. 1999) where it is located in
synaptic terminals of OSNs, periglomerular cell, and projection neurons (mitral and
tufted cells), and it was used to assess overall synaptic density in the GL (Figure 2.4AC). Analysis of the intensity of synaptophysin and TH staining within the GL indicates no
statistically significant changes at any timepoint post-injury when compared to controls.
To assess synaptic markers that were specific to dendritic processes and the
axon terminals of the OSN, VGlut1 and VGlut2 levels within the GL were assessed
(Figure 2.4D-F). VGlut1, which specifically labels the dendritic processes of the
mitral/tufted cells, shows a significant decrease at 2-, 7-, and 14-days post-MM
treatment (Figure 2.4E). Additionally, VGlut2, which specifically labels axon terminals of
OSNs, shows a significant decrease at 2- and 14-days post-MM treatment (Figure
2.4F). There is a return to control levels at 7 DPMM, which could coincide with the initial
arrival of new axons and could reflect both the establishment of new synaptic
connections along with remaining axonal debris leading to a seeming increase in VGlut2
signal within the GL. The following decrease at 14-days post-MM could be attributed to
removal of dead terminals or to a refinement of new connections, as it has been shown
that after injury there is a high level of mistargeting by OSNs (Holbrook et al. 2014). The
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levels of both VGlut1 and VGlut2 return to that of age-matched controls by 40 DPMM,
which indicates a delay in the recovery of synapses within the GL when compared to
the initial arrival of OSN axons shown in our fate-tracing experiments using XFP labeled
axons.

Figure 2.4. Synaptic markers in the GL. A. Representative image of synaptophysin (red)
and TH (green) staining of the GL. B. Synaptophysin quantification. C. TH
quantification. D. Representative image of VGlut1 (red) and VGlut2 (green) staining of
the GL (Note there is little yellow indicating that these two markers are located in
subcellular compartments of two different cell types: dendritic processes of projection
neurons and axons of OSNs respectively). E. VGlut1 quantification. F. VGlut2
quantification. * p≤0.05 vs. control
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Hidden Cookie Test
Finally, to correlate these histological hallmarks with functional recovery of the
olfactory system after an injury, the ability of a mouse to find a hidden cookie was
assessed. Due to preliminary observations of behavior during this test, we also
performed a double-blind analysis of the latency of a mouse to spend a pre-defined time
in the target zone of the hidden cookie. At 3 DPMM, assessment of latency to find the
hidden cookie showed a significant deficit (p<0.05) when compared to saline treated
controls (Figure 2.5A). At 14 DPMM, a reduction in the time to find the hidden cookie
was observed when compared to 3 DPMM, but this time was still significantly different
(p<0.05) than the saline treated controls. Subsequent behavioral testing at 21 and 40
DPMM revealed a reversal of the trend toward recovery to control levels and showed an
increase in latency to find the cookie (Figure 2.5A). A double-blinded analysis then
analyzed latency to the first visit to the cookie zone and found that it mimics the trend on
latency to find the cookie of 3- and 14 DPMM in which a significant deficit is seen at 3
DPMM and there is a trend towards recovery by 14 DPMM which is still significantly
different (p<0.05) from control levels (Figure 2.5B). However, this measure shows a
continuation of the trend toward recovery to control levels at 21- and 40 DPMM and the
latency at 40 DPMM to the cookie zone is no longer significantly different from control
levels. The discrepancy between both assessments at 21- and 40 DPMM could be due
to behavioral changes that are not olfactory in nature but could be associated with long
term side effects of the MM treatment affecting motivation perhaps through interaction
with the thyroid (Cai et al. 2018; Smith and Northcutt 2018).

50

Figure 2.5. Hidden Cookie Test. A. Latency to find cookie. B. Latency to the cookie
zone. * P≤0.05 vs control.
Discussion
The results of this study suggest that despite the shedding of virtually the entire
OE after a MM-induced injury, the timeline for axon extension from the OE to the OB is
unchanged when compared to normal regeneration. This would suggest that
mechanisms behind axon guidance remain intact even after a chemical ablation insult.
Establishing a timeline for extension of OSN axons is critical for the study of
mechanisms underlying axon extension and targeting. The spatiotemporal precision
provided by this Cre-LoxP fate-tracing model used in this study and others (RodriguezGil et al. 2015; Liberia et al. 2019) have established a distinct time course of events and
landmarks for axon extension that can be used in conjunction with mechanistic studies
of OSNs at given timepoints after division from Ascl1+ neural precursors.
While this study found that axons do reach the GL at around 8-10 DPTX (or 911DPMM), our results also indicate a delay in the recovery of synaptic connections
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within the OB. This is further demonstrated by the delay in recovery of olfactory
behavior after injury. It has previously been reported that axonal targeting is less
accurate post-injury (Holbrook et al. 2014), which could suggest that delayed
anatomical and functional recovery is due to refinement that must occur in the synaptic
network of the OB due to inaccurate axonal targeting. Furthermore, the early (but not
significant) rise in colocalization of the newly generated OSNs with OMP after MM
treatment could be indicative of the refinement process that must occur after injury as
OMP has recently been shown to play a role in the refinement of the OB circuitry
(Albeanu et al. 2018).
The results of the hidden cookie test in MM-treated mice indicates that mice do
display abnormal behavior, even at later timepoints post-injury. However, the latency to
the target zone analysis suggests that this altered behavior is not olfactory in nature.
Furthermore, the inhibition in their ability to find the hidden cookie did not appear to
involve altered hunger in the mice as they had been fasted for 23 hours prior to testing
and after testing would eat the cookie when it was removed from the bedding for them.
All of these observations would suggest that a long-term off-target effect from the MM
treatment is present and, in some way, affects the motivation of the mice to dig for the
cookie during testing. MM is used clinically in the treatment of hyperthyroidism and
alterations in motivational behavior have been reported due to alterations in the thyroid
(Cai et al. 2018; Smith and Northcutt 2018). However, the mechanisms behind this
altered behavior is beyond the scope of the current study but would suggest the MM
olfactory injury model is more suited for histo-anatomical studies of olfactory injury
rather than behavioral analysis of olfactory behavior post-injury.
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In summary, the key finding of this study is that despite the arrival of axons to
the GL at around 10 days post-injury, there is a delay of up to 40 days for the synaptic
network refinement. The factors determining the inaccurate targeting of axons and their
subsequent pruning are unknown at this time. Future work can establish the cues that
lead to off-target glomerular targeting as well as the cellular and molecular mechanisms
underlying the pruning and refinement of the OB synaptic network.
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CHAPTER 3. ROLE OF MICROGLIA IN REMOVAL OF AXONAL DEBRIS IN THE
OLFACTORY BULB AFTER A METHIMAZOLE-INDUCED INJURY
Rudy T. Chapman and Diego J. Rodriguez-Gil
Abstract
The ability of the olfactory system to regenerate after an injury is unique in the
nervous system. An established model of injury to the olfactory system is by chemical
ablation through an acute injection of methimazole, which causes the shedding of the
olfactory epithelium. This chemical ablation injury removes the cell bodies of the
olfactory sensory neurons in the epithelium but leaves their axons in place. An element
of regeneration after an injury that is of interest is the mechanism by which cellular
debris from ablated neurons is removed and how this is accomplished in a way that
minimizes inflammation in order to allow for extension of new axons to the olfactory
bulb. Results of this study indicated that microglia infiltration occurs in the olfactory
nerve layer of the olfactory bulb after injury and are capable of phagocytosis of axonal
debris. Furthermore, this infiltration of microglia appears to resolve by 40 days postinjury. Additionally, microglia showed a multinucleated giant cell morphology after injury,
which may play a key role in the removal of debris. Finally, RT-qPCR data from
olfactory bulb tissue post-injury indicated upregulation of CD11b and complement
component 3, suggesting that phagocytosis of axonal debris may involve a
complement-mediated mechanism. Understanding the phagocytotic mechanisms
behind removal of axonal debris after methimazole-induced injury and how this does not
lead to a chronic inflammatory state could lead to more effective treatments for injuries
in other areas of the nervous system.
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Introduction
Olfactory sensory neurons (OSNs) are constantly dying. Despite the constant
turnover of OSNs, the olfactory system has specific mechanisms by which the neural
network responsible for the perception of smell can be regenerated and maintained.
The regenerative capacity of the olfactory system is further enhanced by the ability to
recover from an injury in which part or seemingly the entire olfactory epithelium (OE) is
damaged (Schwob 2002).
Injuries to the olfactory system can be modeled in mice using chemical ablation
of the OE via administration of olfactotoxic agents. These ablation type of injuries lead
to the shedding of the OE, including the immature and mature OSNs, supporting cells,
and some of the basal cells (Schwob and Costanzo 2010). It is estimated that the
mouse OE contains around 10 million OSNs (Kawagishi et al. 2014). This number of
neurons that can be lost in an ablation injury is huge when compared to the estimated
13 million neurons in the mouse cerebral cortex (Herculano-Houzel et al. 2006). Yet,
despite this massive neural injury, the OE and synaptic network within the olfactory bulb
(OB) is able to regenerate both functionally and anatomically to a state which is
seemingly identical to the preinjury system (cf. Chapter 1) (Blanco-Hernández et al.
2012).
Chemical ablation type injuries lead to the shedding of the OE, which removes
the apical dendrites and cell bodies of the OSNs. However, the axons in the lamina
propria and OB remain after such an injury. The cellular phagocyte behind the removal
of axonal debris left from a chemical ablation olfactory injury in a mammalian model has
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yet to be identified. It has been shown that olfactory ensheathing cells (OECs)
phagocytose debris during early development (Nazareth et al. 2015). Furthermore,
OECs have been shown in vitro to phagocytose neuronal debris (Su et al. 2013).
However, an additional potential phagocyte that plays a role in phagocytosis in other
systems, microglia, have been shown to be present in the olfactory nerve as well
(Smithson and Kawaja 2010). It is the goal of this study to identify the role of microglia
in the removal of axonal debris after a methimazole (MM) induced injury within the OB.
Materials and Methods
Animals
12-week-old C57BL/6 mice were ordered from Jackson laboratory and were
treated with either saline or MM (75 mg/kg, Sigma-Adrich: Cat# 46429) and were
collected at 3-, 14-, 21-, and 40-days post injection. Additionally, our Cre-LoxP model
as previously described (Chapter 2 methods) was utilized. In brief, Ascl1CreERT2 mice
(The Jackson Laboratory: stock# 012882) were crossed with either R26RZsGreen (The
Jackson Laboratory: stock# 007906) or R26RTdTomato reporter mice (The Jackson
Laboratory: stock# 007914). Double-heterozygous pups from these crosses were used
at early postnatal timepoints for axonal fate-tracing while Ascl1 wildtype pups were aged
to 3 months and used for OB protein and RNA collection. Double-heterozygous mice
were treated with 4HO-tamoxifen (40 mg/kg, Sigma: Cat# H6278) at post-natal day
(PND) 7. After allowing axons to grow for 10 days to reach the glomerular layer of the
OB (Chapter 2), the mice were injected with either Saline or MM at PND17. Mice were
collected at 3-,7-, 14-, 21-, and 40-days post saline/MM injection. At time of collection,
mice were euthanized and either and had their OB’s removed and flash frozen using dry
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ice or were transcardially perfused with 4% paraformaldehyde (PFA) as previously
described (Chapter 2 methods). Perfused tissue was left in 4% PFA overnight at 4°C
and subsequently decalcified and frozen in OCT. All tissue samples were left at -80°C
until use. All procedures were performed in accordance with the National Institute of
Health Guide for the Care and Use of Laboratory Animals and were approved by the
Institutional Animal Care and Usage Committee of East Tennessee State University.
Immunohistochemistry
Immunohistochemistry was performed as described previously (Chapter 2).
Briefly, 20 µm sections were blocked using 2% bovine serum albumin for 1-2 hours at
room temperature. Primary antibodies were then added and left overnight at 4°C. Slides
were then washed and either Alexa Flour or horse radish peroxidase (HRP) conjugated
secondary antibodies and DAPI (1/1000) were added for 1-2 hours at room
temperature. Stainings using HRP conjugated secondary antibodies were visualized
using Alexa Fluor 488 tyramide reagent (Invitrogen: Cat#B40953). After subsequent
washes, slides were covered with mounting medium and coverslipped. Primary
antibodies and their dilutions were as follows: goat anti-TdTomato (1:1000, Acris: Cat#
AB8181-20), rabbit ant-IBA1 (1/1000, Fujifilm: Cat# 019-19741), rat anti-CD11b (1/50,
BD Pharmingen: Cat# 550282). Images were acquired using a Leica SP6 confocal
microscope.
Western Blot
For Western blot analysis, OB samples were placed in RIPA lysis buffer
(Millipore: Cat# 20-188) with protease and phosphatase inhibitor cocktail (Thermo
Scientific: Cat# 78443) and homogenized using a handheld homogenizer. Samples
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were then left on ice for 30 minutes and then centrifuged at 12000 x g for 15 minutes at
4°C. Supernatant was then collected and protein quantification was carried out using a
BCA assay (Thermo Scientific, Cat# 23227). Protein samples were diluted in Laemmli
buffer plus 2-mercaptoethanol and denatured at 95°C for 5 minutes then loaded into a
15% agarose gel and run through SDS-PAGE. Protein was then transferred to a PVDF
membrane and blocked with 5% milk in TBS-T. Membranes were then probed with a
rabbit anti-IBA1 primary antibody (1/1000, Fujifilm: Cat# 019-19741) diluted in the
blocking buffer and left on a rotator overnight at 4°C. After washes, an HRP conjugated
anti-rabbit antibody was added for 1 hour at room temperature followed by washes. The
PVDF membranes were then treated chemiluminescent HRP substrate (Millipore: Cat#
P90719) and then imaged using a LI-COR Odyssey® imaging system. For a loading
control, membranes were stripped and treated with rabbit anti-actin (1/1000, Cell
Signaling: Cat# 13E5). Band density was quantified and used to compare protein
expression between MM-treated OBs and saline-treated OBs.
RT-QPCR
RNA was isolated from frozen OB samples using TRIzol LS reagent (Ambion:
Cat# 10296010) by following the manufacturer’s instructions. RNA concentrations were
determined using a Biotek Epoch 2 microplate reader and Biotek Take3 microvolume
plate. RNA was then used in a reverse transcription reaction to create 10 ng/µL cDNA.
Between 7.5 and 20 ng of cDNA were used in each PCR reaction. RT-qPCR reactions
were performed using SybrGreen reaction mix (Thermo Scientific: Cat#AB-1323/A) and
an Agilent Technologies Stratagene Mx3000P. PCR reactions took place using the
following protocol: 10 minutes at 95°C; 40 cyclical repeats of 15 seconds at 95°C, 30
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seconds at 62°C, and 30 seconds at 72°C; followed by a disassociation curve protocol
to ensure the creation of only one PCR product.
Primers were designed such that the PCR product would span an intron when
possible in order to amplify mRNA transcripts more specifically and lessen the chance
of genomic DNA contamination being amplified. The following primers were used:
Megf10 forward 5’-TGCAGGAGTCGTATCCACAT-3’; Megf10 reverse 5’TGTCCGGTAGCTGATTCTGT-3’; Jedi1 forward 5’-CTCTCCCGTGACCCATAACT-3’;
Jedi1 reverse 5’-GAGAGACATCTGGCATGACG-3’; Gulp forward 5’GATCTGCTGAGACCAAACGG-3’; Gulp reverse 5’CAAATTAAGCACGTCAGGATCAC-3’; CD11b forward 5’AGGCTCTCAGAGAATGTCCT-3’; CD11b reverse 5’-CGTCCGAGTACTGCATCAAA-3’;
Tlr2 forward 5’-TGTTTCTGAGTGTAGGGGCT-3’; Tlr2 reverse 5’AAGAGCTCGTAGCATCCTCT-3’; Tlr4 forward 5’-AATCCCTGCATAGAGGTAGTTCC3’; Tlr4 reverse 5’-TCTGGATAGGGTTTCCTGTCA-3’; C1qa forward 5’GGAGCATCCAGTTTGATCGG-3’; C1qa reverse 5’-AAACCTCGGATACCAGTCCG-3’;
Complement3 forward 5’-GTAGTGATTGAGGATGGTGTGG-3’; Complement3 reverse
5’-GATGACAGTGACGGAGACATAC-3’. These genes were normalized to the
expression levels of 3 housekeeping genes: β-actin, β2 microglobulin, and TATA box
binding protein. The primers used for the housekeeping genes are as follows: β-actin
forward 5’-CAACGAGCGGTTCCGATG-3’; β-actin reverse 5’GCCACAGGATTCCATACCCA-3’; β2 microglobulin forward 5’TGTCTCACTGACCGGCCTGTATGCT-3’; β2 microglobulin reverse 5’ATTCTCCGGTGGGTGGCGTGAGTAT-3’; TATA forward 5’-
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TGGACCAGAACAACAGCCTTCCAC-3’; TATA reverse 5’CCTGTGCCGTAAGGCATCATTGGA-3’.
Statistics
Data across multiple groups were compared using one-way ANOVA. Data from
qPCR experiments lacked a normal distribution and was analyzed using a KruskalWallis one-way ANOVA. Dunn’s multiple-comparison test was performed to compare
MM-treated groups versus saline-treated controls. A p-value of less than 0.05 was used
to identify a significant difference. Graphical representation of data is displayed as mean
± SEM.
Results
Influx of microglia after MM injury
Our goal in this study was to determine if microglia play a role in the removal of
axonal debris after a MM-induced injury. We performed Western blot studies on OB
tissue to survey levels of a common microglial marker, IBA1, after injury. Protein levels
do appear to increase at 3, 14, and 21 DPMM in the OB and return to levels seen in
saline treated animals by 40 DPMM. However, quantification of these results reveals
these changes are not statistically significant (Figure 3.1).
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Figure 3.1. Western blot of IBA1 in OB tissue post-injury. A. Representative IBA1 blot
showing increase in IBA1 in OB tissue post injury. B. Quantification of these blots reveal
that the change is not significantly different from controls (p=0.097). N=4
While these results did not produce statistically significant results, it was
determined that an increase in IBA1 was possibly underestimated in our area of interest
because we were using homogenates from the entire OB. The OSN axons are located
on the two outermost layers of the OB, the olfactory nerve layer (ONL) and the
glomerular layer (GL). Therefore, it is possible that an increase within these two layers
could be missed by using the entire OB for Western blotting. With this in mind, we
performed immunofluorescent staining on OB tissue post-injury to achieve a higher
resolution of the changes of IBA1+ cells on the individual layers of the OB.
Immunofluorescent staining revealed that IBA1+ cells increase specifically within the
ONL at 3, 14, and 21 DPMM, which reflects the changes seen in the Western blot
(Figure 3.2). In contrast to the morphology seen in the inner layers of the OB where
IBA1+ microglia appear with long thin processes, indicating resting microglia, the IBA1+
cells in the ONL display an amoeboid morphology consistent with an activated microglia
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phenotype. Additionally, the greater density of IBA1+ cells within the ONL appears to
have resolved by 40 DPMM, which is consistent with the Western blot findings, as well
as our previous study which indicated recovery of synaptic markers and olfactory
behavior by 40 DPMM (Chapter 2).

Figure 3.2. Immunofluorescent staining of IBA1+ cells (green) in the OB post-injury. GLglomerular layer, ONL-olfactory nerve layer. Scalebar- 50 µm.

Microglia display MGC phenotype after injury
While examining the IBA1 staining post-injury in the OB, it was noted that there
were some cells in the ONL that displayed very large cell bodies, and some had a
fainter staining pattern compared to others (Figure 3.3A-B). Higher magnification
imaging revealed that some of these large cells contained multiple nuclei (Figure 3.3C64

E). These observations are consistent with what has been previously reported as
multinucleated giant cells (MGCs) (Hornik et al. 2014). MGCs are reported to be a
highly phagocytic form of either microglia or macrophages (Hornik et al. 2014; Milde et
al. 2015) and thus it is possible that this cell type is formed due to the massive amount
of debris created within the OB after chemical ablation of the OSNs. There are
conflicting reports of how MGCs are formed. It has been reported that MGCs form due
to fusion of cells (Helming and Gordon 2009). However, it has also been shown that
MGCs can be formed by inhibition of cytokinesis (Hornik et al. 2014). While it is difficult
to conclusively demonstrate this process in vivo, we did find an example of an IBA1+
cell undergoing nuclear division in the GL immediately proximal to the ONL at 3 DPMM
(Figure 3.4), suggesting that the MGCs seen in the OB are formed due to an inhibition
of cytokinesis.
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Figure 3.3. Immunofluorescent staining showing IBA+ cells in the ONL of the OB
showing multinucleated giant cell morphology at 14DPMM. A-B: Cross-section of
14DPMM OB shows large IBA1+ cells (white arrows) in the ONL. C-E: Higher mag
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images show an example of one of these large cells with multiple nuclei (white arrows).
Scalebar-20 µm.

Figure 3.4. OB tissue from 3 DPMM showing an IBA1+ cell undergoing nuclear division.
Scalebar- 20 µm
Phagocytosis of labeled OSN axons by microglia
In order to examine phagocytosis of axonal debris, we used a fate-tracing
approach using our Cre-LoxP model used in our previous study (Chapter 2). After
inducing expression of the fluorescent reporter, axons were allowed 10 days to grow to
the OB and then an injection of either MM or saline was given. Tissue was collected at
3-, 7-, 14-, 21-, and 40-days post-MM/saline injection. Tissue was then stained with an
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IBA1 antibody and confocal imaging was performed to determine if the IBA1+ cells in
the ONL contained fluorescently labeled axonal debris. We were able to detect axonal
debris within IBA1+ cells as early at 7DPMM (not shown), and also at 14DPMM (Figure
3.5A-B) and 21DPMM (Figure 3.5C-D). Our imaging did not show any debris within
IBA1+ cells at 40DPMM (not shown) and fluorescently labeled axons were largely
absent from the ONL. It is important to note that the fluorescently labeled axons (red)
were born 24 (Figure 3.5A-B) and 31 (Figure 3.5C-D) days before the tissue was
collected and have been dead for 14 (Figure 3.5A-B) and 21 (Figure 3.5C-D) days.
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Figure 3.5. IBA1+ cells (green) phagocytose fluorescently labeled axons (red). A:
Projection image of IBA1+ cells at 14DPMM phagocytosing labeled axons (arrows
indicate yellow areas indicating colocalization). B: Cross-sectional analysis of the same
image shows the axon indicated is contained within the IBA+ cell. C: Projection image of
an IBA1+ cell at 21DPMM with a large piece of fluorescently labeled debris inside the
cell body. D: Cross sectional analysis of the same image shows the piece of labeled
debris is contained inside the IBA1+ cell. Scalebar- 10 µm.
Molecular mechanisms of phagocytosis
The molecular pathway underlying phagocytosis in the mammalian olfactory
system after injury has not yet been defined. However, a molecular pathway has been
described in ensheathing glial cells for the engulfment of axonal debris in D.
melanogaster (Doherty et al. 2009; Doherty et al. 2014; Musashe et al. 2016). This
pathway involves the receptor Draper, which has a mammalian homolog Jedi-1 that has
been characterized to be involved in the engulfment process of phagocytosis, along with
another receptor, Megf10, and an adaptor protein ,GULP, both in vitro and in glial
precursor cells (Wu et al. 2009; Sullivan et al. 2014). So, we utilized qPCR to analyze
expression of Jedi-1, GULP, and Megf10 in the OB after MM-induced injury (Figure 3.6).
Our results show that expression levels of Jedi-1 and GULP after injury are not
significantly altered at 3-, 14-, and 21-days post-injury. We did see a significant change
in Megf10 expression at these times. However, this change was a significant decrease
in Megf10 expression. At 40 DPMM, neither Jedi-1 nor Megf10 were significantly
different from saline treated subjects. GULP, however, shows a significant increase at
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40 DPMM, which could indicate a late stage reaction within the OB that occurs after
other markers of the injury seem to have recovered.

2.0

1.5
1.0
0.5
0.0

1.5
1.0
0.5

3

14

21

40

Days post injury

Megf-10

1.5
1.0

*
*

*

14

21

0.5
0.0

0.0
Sal

2.0

*

Gulp

Folds change

Jedi -1

Folds change

Folds change

2.0

Sal

3

14

21

Days post injury

40

Sal

3

40

Days post injury

Figure 3.6. qPCR quantification of Jedi-1, GULP, and Megf10 after injury. (n=5, *
p≤0.05).
Another receptor that has been shown to be play a role in phagocytosis of
cellular debris is CD11b (integrin αM subunit). CD11b is also expressed on microglia,
which we have shown infiltrate the ONL after a chemical ablation injury. So, we
analyzed expression of CD11b after MM-induced injury by qPCR and found an increase
at 3DPMM that was not statistically significant. We did, however, find a significant
increase at 14- and 21DPMM. At 40DPMM, expression of CD11b had returned to
control levels (Figure 3.7).
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Figure 3.7. qPCR quantification of CD11b. (n=5, * p≤0.05)
To verify the expression of CD11b in microglia within the OB, we co-stained
CD11b with IBA1. Immunostaining showed very little CD11b in saline treated OBs but
CD11b did colocalize well with IBA1 in the ONL (Figure 3.8A). At 3- and 14 DPMM,
however, there was a clear upregulation of CD11b in the ONL, which mimicked the
upregulation of IBA1 after injury (Figure 3.8B-C). Higher magnification imaging at
14DPMM shows a very clear colocalization of CD11b and IBA1 in the ONL and can be
seen on IBA1+ cells with multiple nuclei (Figure 3.8D-G).
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Figure 3.8. Immunofluorescent staining of IBA1 (Red) and CD11b (Green) in the OB. A:
Saline. B: 3DPMM. C: 14DPMM. D-G: High magnification images show IBA1+ cells with
multiple nuclei (white arrows) also expressing CD11b. Scalebar-20µm.
CD11b, also known as the alpha subunit of complement receptor 3, has been
shown to play a role in complement mediated phagocytosis (Van Strijp et al. 1993).
Furthermore, MGCs have been shown to be specialized in the phagocytosis of
complement coated debris (Milde et al. 2015). So, with the upregulation of CD11b after
injury and the appearance of an MGC morphology in the ONL, we decided to analyze
components of the complement pathway to explore a possible mechanism for the
removal of OSN axons after injury. We analyzed the expression of two components of
complement as well as a second integrin receptor that has been shown to be involved in
complement-mediated phagocytosis. Complement component C3b has been shown to
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bind to CD11b and is produced, along with C3a, by proteolytic cleavage of the
complement 3 protein that is translated from a single mRNA for complement 3 (Comp3).
Our results show an upregulation in Comp3 that mimics the trend of CD11b post injury
with an increase (albeit not statistically significant) at 3DPMM and a larger, statistically
significant increase at 14- and 21 DPMM (Figure 3.9A-note scale break in graph).
Comp3 does appear to still be increased at 40 DPMM but this increase is no longer
statistically significant (Figure 3.9A) It is possible with a larger number of samples or an
analysis of protein expression would show that Comp3 is still significantly elevated at
40DPMM. An additional component of the complement pathway is C1qa, which has
been shown to be produced by microglia and plays a role in synaptic pruning (Fonseca
et al. 2017). Our results do seem to indicate an elevation in this mRNA, but the changes
seen at 3-, 14-, and 21 DPMM are not statistically significant. The last component in our
analysis of the complement mechanism was another integrin receptor, CD11c (integrin
αX, alpha subunit of complement receptor 4), which has also been shown to play a role
in complement mediated phagocytosis (Lukácsi et al. 2017). CD11c shows no change
at 3DPMM but a significant increase at 14- and 21DPMM (Figure 3.9C), again showing
upregulation of components of the complement pathway at these timepoints. C1qa and
CD11c have not yet been analyzed at 40DPMM, but expression of both of these
mRNAs at 40DPMM will be analyzed soon.
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Figure 3.9. qPCR quantification of Comp 3 (A- Note break in scale), C1qa (B), and
CD11c (C) after injury. (n=3-5, * p≤0.05)
Finally, an additional class of receptor that is classically associated with the
innate immune response is the toll-like receptor (TLR). TLRs have also been shown in
the central nervous system to play a role in neurodegeneration and injury response
(Kielian 2006) and are associated with the activation of phagocytic mechanisms (Doyle
et al. 2004). So, we analyzed expression of two TLRs, TLR2 and TLR4, in the OB postinjury via qPCR. TLR2 shows a significant increase in expression at 3DPMM but all
other timepoints show no significant difference from saline treated controls (Figure
3.10A). TLR4, however, showed no significant change after injury when compared to
controls (Figure 3.10B).
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Figure 3.10. QPCR quantification of (A) TLR2 and (B) TLR4 expression post-injury.
(n=5, * p≤0.05)
Discussion
The findings of this study implicate a role of microglia in removal of axonal debris
after a MM-induced injury. While OECs have been suggested to be the primary
phagocytes of the olfactory bulb (Suzuki et al. 1996; Su et al. 2013), our results indicate
that influx of IBA1+ cells and expression of molecular markers correlated with
phagocytosis suggest that microglia may also be involved after a large injury. This,
however, does not necessarily mean that the OECs do not also participate in the
phagocytic process after an injury but instead may suggest that the microglia may be
needed in response to the large amount of neuronal debris created after a chemical
ablation of the OE.
As previously mentioned, Draper has been shown in D. melanogaster to be
involved in the phagocytic process of axonal debris (Doherty et al. 2009; Musashe et al.
2016). Our results regarding the mammalian homolog, Jedi-1, along with other
associated components of this phagocytic pathway, indicate either no change or a down
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regulation of this pathway. The Draper pathway is associated with ensheathing glia in
the D. melanogaster model. The lack of change or downregulation we see in our mouse
model could indicate that phagocytosis by OECs does not increase due to the influx of
microglia. At 40 DPMM, Jedi-1 and Megf10 are once again at control levels of
expression and GULP has a significant increase. This could suggest that as the
microglia influx has dissipated as shown by our IBA1 staining, that OECs once again
take on primary responsibility of phagocyte in the olfactory bulb after the bulk of the
debris has been removed after injury. Therefore, we hypothesize that both cell types are
associated with axon debris removal, with microglia being recruited after larger insults.
The appearance of the MGC phenotype in the ONL was an unexpected finding
that could have important implications in how the OB is able to remove a huge amount
of debris and restore the complex synaptic network after injury. MGCs have been
shown to specialize in removal of complement coated debris (Milde et al. 2015) and our
results indicating upregulation of both receptors (CD11b and CD11c) and complement
components (Comp3 and C1qa) could suggest a mechanism by which MGCs
phagocytose axonal debris in the OB. However, the upregulation of these receptors and
components do not necessarily define a full mechanism nor implicate solely the MGCs
or microglia in this process. Further studies will be required to fully explore this
mechanism and also determine the origin of the IBA1+ cells seen in the ONL to verify
that these are microglia and not infiltrating macrophages from the periphery.
Another finding with potentially impactful implications was the early upregulation
of TLR2 at 3DPMM. This was the only marker analyzed that was upregulated
significantly at this timepoint. TLRs are known to activate phagocytic pathways (Doyle et
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al. 2004) and this could be a key receptor for activating the response to the large
amount of axonal debris created after an injury. Furthermore, TLR2 has been correlated
with the release of anti-inflammatory cytokines (Mckimmie et al. 2009) and this early
upregulation may play a role in modulating the inflammatory response in the OB that
prevents a long term inflammation and thus allows for recovery of the synaptic network.
While there are still further studies required to fully understand the role of
microglia in the response to a MM-induced injury in the OB, the findings in this study
could play a key role in our understanding of the removal of axonal debris after injury.
Furthermore, understanding the role of both the OEC and microglia in this process and
how the two interact may provide key insights into the efficiency of the OB’s removal of
debris and ability to recover. The ability of the olfactory system to recover after an injury
and reestablish synaptic connections is unparalleled in other areas of the CNS and
understanding further how this is able to occur can lead to the discovery of mechanisms
that are translatable to injuries in other areas of the nervous system.
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CHAPTER 4. CONCLUSIONS
Despite a large body of work involving the study of regeneration in the olfactory
system, there are still many fundamental questions that remain unanswered. The
precision by which axons find synaptic targets is daunting and many molecules have
been associated with this process. There is no single molecule that is responsible for
synaptic targeting but instead a variety of molecules produce a combinatorial effect that
results in the axonal targeting of a specific glomerulus (Mombaerts 2006). This happens
not only during development, but also throughout life in terms of both normal cell
turnover and in response to an injury when new OSNs are born. To understand how
axons continually grow throughout the life of an organism and find synaptic targets with
such precision could be key to developing more effective treatments for neurological
disorders and injuries.
The data presented in this work lays groundwork for a fundamental
understanding of how OSN axons regrow after an injury. Axonal fate tracing revealed
that control and post-injury axons reach specific landmarks for extension from the OE to
the OB at similar times. This would suggest that the molecular machinery responsible
for axonal growth is intact in a post-injury system and axons are not inhibited in their
growth due to debris, glial scarring, or inflammation. These latter factors have been
attributed to the lack of axonal growth and regeneration in other CNS injuries (Fitch and
Silver 2008). Despite axons reaching the GL around 8-10 days, our data suggest that
anatomical and functional recovery in the olfactory system may take up to 40 days. It
has been reported previously that axonal targeting after injury is less accurate and
axons can target other glomeruli proximal to their intended glomeruli (Holbrook et al.
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2014). Our data has also shown that there is an influx of microglia into the ONL after
injury and activated microglia have been shown to inhibit axonal growth (Kitayama et al.
2011). So, it is possible that an injury-induced increase in microglia can play a role in
the altered axonal targeting of OSNs and a delay in recovery.
While there was a significant level of microglia infiltration into the ONL after
injury, it is also important to note that the levels of microglia return to near control levels
by 40DPMM. This correlates with the time we observed recovery of synaptic markers in
the GL and functional behavior in the hidden cookie test. It may be that the microglia are
necessary to deal with the large load of axonal debris generated from the injury, but
their presence is inhibitory to accurate axonal targeting. After the microglial infiltration is
resolved, the axons are no longer inhibited by the presence of the microglia and axonal
targeting can regain its precision. However, further studies will be needed to assess the
role of microglia and axonal targeting in the olfactory bulb and if their activated state
after an injury is deleterious to glomerular targeting by newly born neurons.
Another important note regarding the resolution of microglial infiltration in the
olfactory bulb is that despite the presence of axonal debris from an estimated 10 million
dead OSNs (Kawagishi et al. 2014), microglial activation and neuroinflammation does
not appear to become chronic in the OB after injury. Microglial activation and
neuroinflammation are important topics of discussion as they are often seen as
precursors to neurodegenerative disease, such as Alzheimer’s disease and
amyotrophic lateral sclerosis (Fendrick et al. 2007; Yoshiyama et al. 2007).
Furthermore, microglial activation and increase expression levels of the complement
component C1q have been associated with a neurodegenerative condition involving the
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visual axis after a retinal injury (Silverman et al. 2016). However, despite the injury
suffered by the OB, our results thus far seem to indicate a resolution of microglial
activation and seems to suggest that the OB does not enter into a state of chronic
inflammation after injury. The OB seems to have mechanisms in place that aid in
dealing with inflammation that have not yet been defined. In a study designed to mimic
chronic nasal inflammation by repeated intranasal injection of lipopolysaccharide (LPS),
the OB was shown to be atrophic during the chronic inflammation but was able to return
to levels consistent with the OB prior to LPS treatment upon cessation of the injections
(Hasegawa-Ishii et al. 2019). Receptors involved in mediation of inflammatory
responses would be of great interest in defining how the OB is able to endure a largescale injury without entering into a state of chronic neuroinflammation. While our results
do seem to reflect that the OB is able to undergo an injury without displaying signs of
neuroinflammation in the time course of our study, it would be useful to assess the longterm condition of the olfactory bulb post-injury as compared to age-matched controls to
determine if there are long-term detriments caused from a chemical ablation injury.
Furthermore, it would also be valuable to explore susceptibility and response to further
injury.
While our results regarding phagocytosis focused on the role of microglia, the
role of the OEC in this process should not be overlooked. The OEC has previously been
shown to be involved in phagocytosis in the OB (Su et al. 2013) and the influx of
microglia does not necessarily mean that the OECs don’t contribute to the removal of
axonal debris after injury. Our results show that Jedi-1, GULP, and Megf10 are either
unchanged or downregulated at the times when we see infiltration of microglia in the
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ONL. Based on the Jedi-1 homology with Draper and its association with ensheathing
glia in D. melanogaster (Doherty et al. 2009; Doherty et al. 2014; Musashe et al. 2016),
we hypothesis that these three markers are expressed on the mammalian OEC and
may underly phagocytosis during normal regeneration. However, their expression on
OECs would need to be confirmed with immunohistochemical staining and their role in
phagocytosis during normal regeneration would require further study.
While it is plausible that Jedi-1, GULP, and Megf10 are the molecular pathway
underlying OEC phagocytosis and microglia phagocytose axonal debris via
complement, there are multiple other pathways that have been described to be involved
in phagocytosis (Sierra et al. 2013). Of note are a group of receptor tyrosine kinases in
the TAM (Tyro3, Axl, and Mertk) family that have been associated with microglial
phagocytosis and the deletion of these receptors leads to increased inflammation
(Grommes et al. 2008; Weinger et al. 2011). It would be valuable analyze other
receptors involved in phagocytosis, such as the TAM family, to see if other receptors
may be involved in the phagocytic process. CD11b has been described in functions
other than phagocytosis, such as adhesion and migration (Zen et al. 2011; Hyun et al.
2019). Therefore, the upregulation of CD11b seen in our experiments does not
necessarily conclude that CD11b is the receptor underlying phagocytosis. The increase
in expression and colocalization with microglia does, however, warrant further
investigation into the role of CD11b in microglia response to injury in the OB.
While the OEC’s role in post-injury debris removal is undetermined at this point,
OECs do have other roles that make them of further interest in regeneration. There is
great interest in cellular transplantation using the OEC in injuries such as spinal cord
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injuries (Mayeur et al. 2013; Gómez et al. 2018). The OEC is believed to allow axonal
growth in the presence of a glial scar, which again is often attributed to the inhibition of
axonal growth in the CNS (Moreno-Flores et al. 2002; Fitch and Silver 2008). As there is
a large increase in microglia within the ONL after injury and it has been established that
microglia can inhibit axonal growth (Kitayama et al. 2011), it would be valuable to
determine if OECs are critical for the growth of new axons among the influx of microglia
in the OB and what mechanism OECs employ to create an environment that is
conducive to axon growth. A greater understanding of the molecular mechanisms that
OECs employ to allow for axon growth would have great value in translation to
treatments of other neural injuries.
Finally, the results of this study and others using this fate tracing method for
mapping regrowth of axons (Rodriguez-Gil et al. 2015; Liberia et al. 2019), have
established distinct timelines for axonal growth. The spatiotemporal resolution of this
technique can be utilized in conjunction with more mechanistic approaches, such as
using in conjunction with RNA sequencing, to uncover mechanisms responsible for
certain aspects of axon growth and axon guidance with a precision that has not been
produced to this point. Correlating axon growth landmarks with the onset of expression
of certain genes known to be involved in axon guidance could begin to unravel the large
puzzle that is axon guidance in the olfactory system.
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